Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis

Abstract Although biomarker candidates associated with psoriasis have been suggested, those for predicting the risk of cardiovascular disease (CVD) early in patients with psoriasis are lacking. We aimed to identify candidate biomarkers that can predict the occurrence of CVD in psoriasis patients. We...

Full description

Bibliographic Details
Main Authors: Na Young Kim, Ji Hyun Back, Jong Hwan Shin, Mi-Jung Ji, Su Jin Lee, Yae Eun Park, Hyun-Mee Park, Man Bock Gu, Ji Eun Lee, Jeong Eun Kim
Format: Article
Language:English
Published: Nature Portfolio 2023-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-30103-2
_version_ 1797864711590510592
author Na Young Kim
Ji Hyun Back
Jong Hwan Shin
Mi-Jung Ji
Su Jin Lee
Yae Eun Park
Hyun-Mee Park
Man Bock Gu
Ji Eun Lee
Jeong Eun Kim
author_facet Na Young Kim
Ji Hyun Back
Jong Hwan Shin
Mi-Jung Ji
Su Jin Lee
Yae Eun Park
Hyun-Mee Park
Man Bock Gu
Ji Eun Lee
Jeong Eun Kim
author_sort Na Young Kim
collection DOAJ
description Abstract Although biomarker candidates associated with psoriasis have been suggested, those for predicting the risk of cardiovascular disease (CVD) early in patients with psoriasis are lacking. We aimed to identify candidate biomarkers that can predict the occurrence of CVD in psoriasis patients. We pursued quantitative proteomic analysis of serum samples composed of three groups: psoriasis patients with and those without CVD risk factors, and healthy controls. Age/Sex-matched serum samples were selected and labeled with 16-plex tandem mass tag (TMT) and analyzed using liquid chromatography-mass spectrometry and subsequent verification with ELISA. Of the 184 proteins that showed statistical significance (P-value < 0.05) among the three groups according to TMT-based quantitative analysis, 98 proteins showed significant differences (> 2.0-fold) between the psoriasis groups with and without CVD risk factors. Verification by ELISA revealed that caldesmon (CALD1), myeloid cell nuclear differentiation antigen (MNDA), and zyxin (ZYX) levels were significantly increased in the psoriasis group with CVD risk factors. Further network analysis identified pathways including integrin signaling, which could be related to platelet aggregation, and actin cytoskeleton signaling. Three novel candidates (MNDA, ZYX, and CALD1) could be potential biomarkers for predicting CVD risks in psoriasis patients. We expect these biomarker candidates can be used to predict CVD risk in psoriasis patients in clinical settings although further studies including large validation are needed.
first_indexed 2024-04-09T22:57:33Z
format Article
id doaj.art-ad1ba6c60df349aca87c1360d38deb15
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-09T22:57:33Z
publishDate 2023-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-ad1ba6c60df349aca87c1360d38deb152023-03-22T11:13:12ZengNature PortfolioScientific Reports2045-23222023-02-0113111310.1038/s41598-023-30103-2Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasisNa Young Kim0Ji Hyun Back1Jong Hwan Shin2Mi-Jung Ji3Su Jin Lee4Yae Eun Park5Hyun-Mee Park6Man Bock Gu7Ji Eun Lee8Jeong Eun Kim9Department of Dermatology, Hanyang University College of MedicineDepartment of Biotechnology, College of Life Sciences and Biotechnology, Korea UniversityAdvanced Analysis and Data Center, Korea Institute of Science and TechnologyAdvanced Analysis and Data Center, Korea Institute of Science and TechnologyChemical & Biological Integrative Research Center, Biomedical Research Institute, Korea Institute of Science and TechnologyChemical & Biological Integrative Research Center, Biomedical Research Institute, Korea Institute of Science and TechnologyAdvanced Analysis and Data Center, Korea Institute of Science and TechnologyDepartment of Biotechnology, College of Life Sciences and Biotechnology, Korea UniversityChemical & Biological Integrative Research Center, Biomedical Research Institute, Korea Institute of Science and TechnologyDepartment of Dermatology, Hanyang University College of MedicineAbstract Although biomarker candidates associated with psoriasis have been suggested, those for predicting the risk of cardiovascular disease (CVD) early in patients with psoriasis are lacking. We aimed to identify candidate biomarkers that can predict the occurrence of CVD in psoriasis patients. We pursued quantitative proteomic analysis of serum samples composed of three groups: psoriasis patients with and those without CVD risk factors, and healthy controls. Age/Sex-matched serum samples were selected and labeled with 16-plex tandem mass tag (TMT) and analyzed using liquid chromatography-mass spectrometry and subsequent verification with ELISA. Of the 184 proteins that showed statistical significance (P-value < 0.05) among the three groups according to TMT-based quantitative analysis, 98 proteins showed significant differences (> 2.0-fold) between the psoriasis groups with and without CVD risk factors. Verification by ELISA revealed that caldesmon (CALD1), myeloid cell nuclear differentiation antigen (MNDA), and zyxin (ZYX) levels were significantly increased in the psoriasis group with CVD risk factors. Further network analysis identified pathways including integrin signaling, which could be related to platelet aggregation, and actin cytoskeleton signaling. Three novel candidates (MNDA, ZYX, and CALD1) could be potential biomarkers for predicting CVD risks in psoriasis patients. We expect these biomarker candidates can be used to predict CVD risk in psoriasis patients in clinical settings although further studies including large validation are needed.https://doi.org/10.1038/s41598-023-30103-2
spellingShingle Na Young Kim
Ji Hyun Back
Jong Hwan Shin
Mi-Jung Ji
Su Jin Lee
Yae Eun Park
Hyun-Mee Park
Man Bock Gu
Ji Eun Lee
Jeong Eun Kim
Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis
Scientific Reports
title Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis
title_full Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis
title_fullStr Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis
title_full_unstemmed Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis
title_short Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis
title_sort quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis
url https://doi.org/10.1038/s41598-023-30103-2
work_keys_str_mv AT nayoungkim quantitativeproteomicanalysisofhumanserumusingtandemmasstagstopredictcardiovascularrisksinpatientswithpsoriasis
AT jihyunback quantitativeproteomicanalysisofhumanserumusingtandemmasstagstopredictcardiovascularrisksinpatientswithpsoriasis
AT jonghwanshin quantitativeproteomicanalysisofhumanserumusingtandemmasstagstopredictcardiovascularrisksinpatientswithpsoriasis
AT mijungji quantitativeproteomicanalysisofhumanserumusingtandemmasstagstopredictcardiovascularrisksinpatientswithpsoriasis
AT sujinlee quantitativeproteomicanalysisofhumanserumusingtandemmasstagstopredictcardiovascularrisksinpatientswithpsoriasis
AT yaeeunpark quantitativeproteomicanalysisofhumanserumusingtandemmasstagstopredictcardiovascularrisksinpatientswithpsoriasis
AT hyunmeepark quantitativeproteomicanalysisofhumanserumusingtandemmasstagstopredictcardiovascularrisksinpatientswithpsoriasis
AT manbockgu quantitativeproteomicanalysisofhumanserumusingtandemmasstagstopredictcardiovascularrisksinpatientswithpsoriasis
AT jieunlee quantitativeproteomicanalysisofhumanserumusingtandemmasstagstopredictcardiovascularrisksinpatientswithpsoriasis
AT jeongeunkim quantitativeproteomicanalysisofhumanserumusingtandemmasstagstopredictcardiovascularrisksinpatientswithpsoriasis